Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments.
Suzuki H, Iwamoto H, Nakano M, Nakamura T, Masuda A, Sakaue T, Tanaka T, Nakano D, Kuromatsu R, Niizeki T, Okamura S, Shimose S, Shirono T, Noda Y, Kamachi N, Yano H, Kawaguchi A, Koga H, Torimura T.
Suzuki H, et al. Among authors: kuromatsu r.
Transl Oncol. 2021 Nov;14(11):101201. doi: 10.1016/j.tranon.2021.101201. Epub 2021 Aug 11.
Transl Oncol. 2021.
PMID: 34388691
Free PMC article.